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A simple, convenient and accurate indirect titrimetric method and a rapid, sensitive and precise
indirect spectrophotometric method for the determination of six phenothiazine drugs using chloramineT as an oxidant are described.

The titrimetric method is based on the oxidation of the drugs in

sulphuric acid medium by a known excess of chloramine-T and iodometric determination of the unreacted
chloramine-T. In the spectrophotometric method, the unreacted oxidant is made to react with metol in
the presence of an aromatic amine to produce a purple-red product with the absorption maximum at
520 nm. The absorbance is found to decrease linearly with increasing concentration of drugs, which is
corroborated by the calculated correlation coefficient values in the range -0.9920 to -0.9999. The systems
obey Beer’s law for 5-150 µg ml−1 of drugs. The molar absorptivities are around 2.00 x 103 1 mol−1
cm−1 and relative standard deviations (RSD) are less than 2% (n=7). The proposed methods were
successfully applied in the determination of studied phenothiazines in pharmaceutical formulations. The
reliability of the assay methods was established by parallel determination by the BP method.

Introduction
N-substituted phenothiazine derivatives have a profound psychotherapeutic activity 1 and hence are used
in the treatment of various mental illnesses. They also possess sedative, antihistaminic, antiemetic, antipruritic and anaesthetic properties2 . The importance of phenothiazine tranquillisers has prompted many
investigators to look for methods for their rapid determination. Numerous methods developed for the determination of these biological important compounds have been reviewed3−5 . The official method is based
on non-aqueous titration or spectrophotometry of the pure drug or its dosage forms6,7 . Many titrimetric
methods based on oxidation by oxidizing agents such as hexacyanoferrate8 , ammonium metavanadate9 , Nbromosuccinimide and other brominating agents10 and l-chlorobenzotriazole11 have been proposed. Most
other methods are based on oxidation prior to analytical measurement. Typical oxidants used are potassium
iodate12 , ammonium molybdate13, ammonium metavanadate14, hexacyanoferrate(III)15 , nitroprusside16 ,
∗ Author

to whom correspondence should be addressed.

551

Titrimetric and Spectrophotometric Determinations of..., K. BASAVAIAH, J. MANJUNATHASWAMY
N-bromophthalimide17 iron (III) chloride18 and iodic acid19 and the final products are determined by spectrophotometry. Spectrofluorimetry has also been used after oxidation by N-bromosuccinimide20 and cerium
(IV)21 . Even potentiometry22 with an oxidative column in a flow injection system has been applied. Highperformance liquid chromatography (HPLC)23 with electrochemical detection has been proposed for the
determination of phenothiazines in pharmaceuticals and human serum. Other methods proposed for the
assay of phenothiazines include potentiometry24,25 , voltammetry26,27, differential spectrophotometry28 and
chemiluminescene spectroscopy29,30 .
The use of chloramine-T as an oxidimetric reagent was first proposed by Noll31 and, since then, a
large number of compounds of pharmaceutical interest32−38 have been determined using chloramine-T. A
titrimetric procedure39 based on the oxidation of drugs with iodine monochloride in strong hydrochloric acid
medium and titrating the liberated iodine with chloramine-T by the Andrews method has been proposed
for phenothiazines. The procedure is highly cumbersome. It employs highly acidic conditions (20 ml
concentrated HCl for 10 ml drug solution), uses the presence of alcohol and requires vigorous shaking.
In addition the procedure is applicable only to 20-100 mg of drugs. Issa et al.40 have used chloramine-T
as a chromogenic reagent for the spectrophotometric determination of some phenothiazines. However the
method has many disadvantages, including the use of alcoholic solutions, heating in a water bath for a long
time and, above all, poor sensitivity.
In this work, a simple and convenient titrimetric procedure and a rapid, accurate and sensitive
spectrophotometric method utilising chloromine-T as an oxidimetric reagent are proposed. The methods are
applicable to the determination of bulk drugs and dosage forms.

Experimental
Apparatus
A Systronics model 106 digital spectrophotometer with 1 cm matched quartz cells was used for absorbance
measurements. An Elico model L1 digital pH meter was used for pH measurements.

Reagents
All chemicals used were of analytical-reagentgrade.
Chloramine-T (0.015 M and 500 µgml −1 ): A 0.015 M chloramine-T solution was prepared by
dissolving 4.22 g of the reagent in distilled water and diluting to one litre. This solution was standardised
iodometrically and then diluted stepwise to get 500 µgml−1 solution for spectrophotometric work.
Sodium thiosulphate (0.02 M): This was prepared by dissolving 5.00 g of the sample in distilled
water and diluting to one litre with the same solvent. This solution was standardised iodometrically using
potassium dichromate.
Starch indicator (1%): A paste of 1.0 g of soluble starch with a little distilled water was made and
it was poured, with constant stirring, into 100 ml of boiling water, boiled for a minute and cooled.
Sulphuric acid (5 M): Prepared by diluting 556 ml of concentrated sulphuric acid (d = 1.84) to
two litres with distilled water.
Walpole buffer (pH 2.71): This was prepared by mixing 50 ml of 1 M sodium acetate and 50 ml
of 1 M hydrochloric acid and diluting to 250 ml with distilled water41 .
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Metol (0.2%): This was prepared by dissolving 0.2 g of the sample in 100 ml of distilled water just
before use.
Sulphanilic acid (0.1%): This was prepared by dissolving 0.1 g of the sample in 100 ml of distilled
water just before use.

Standard solutions of phenothiazine drugs
Pure drug samples were kindly provided by many pharmaceutical companies and were used as received. Stock
standard solutions containing 2000 µgml−1 drugs were prepared by dissolving accurately weighed amounts
of chlorpromazine hydrochloride (CPH), promethazine hydrochloride (PH), triflupromazine hydrochloride
(TPH), trifluoperazine hydrochloride (TFPH), thioproperazine mesylate (TPPM) and prochlorperazine
mesylate (PCPMS) in distilled water. The solutions were kept in amber-coloured bottles and stored in
a refrigerator. Each solution was further diluted suitably to obtain 400-800 µgml−1 drug solutions for
spectrophotometric work.

Procedures
Titrimetry: A 10 ml aliquot of drug solution containing 1-10 mg of TPH, PH or TFPH or 1-7 mg of CPH
or 2-14 mg of TPPM or PCPM was transferred into a 100 ml titration flask followed by the addition of 2-5
ml of 5 M sulphuric acid (Table 1) and 10 ml of 0.015 M chloramine-T solution. The reaction mixture was
shaken occasionally and, after a specified time (Table 1), 5 ml of 10% potassium iodide was added and the
liberated iodine was titrated against 0.02 M sodium thiosulphate solution using starch indicator. A reagent
blank was also run under under identical conditions using all the reagents except the drug. The amount
of the drug was calculated from the number of equivalents of chloramine-T consumed in the reaction with
phenothiazines.
Table 1. Analytical data for the titrimetric determination of phenothiazines

Drug
Studied
CPH
PH
TPH
TFPH
TPPM
PCPMS

Volume of
5M
H2 SO4
3
5
3
3
2
2

Reaction
time
(min)
30
25
30
30
30
25

Molar ratio,
Drug: oxidant

Range
(mg)

Recovery*
(%)

1:2
1:2
1:2
1:2
1:2
1:2

1-7
1-10
1-10
1-10
2-14
2-14

100.00
100.86
99.40
100.20
100.00
99.70

RSD
(%)
(n=6)
1.31
1.67
1.02
2.58
1.96
1.60

* Average of six determinations each containing 5 mg of CPH, PH, TPH or TFPH, 10 mg of TPPM or PCPM

Spectrophotometry: In each of the series of 10 ml calibrated flasks was placed 1.5 ml of 500 µgml−1
chloramine-T solution followed by 0.0-2.0 ml of TPH, TFPH or PCPMS (500 µgml−1), PH or CPH (400
µgml−1 ) or TPPM (800 µgml−1). The contents were mixed well and set aside for 1 min or until the
disappearance of the red, reddish-purple or orange colour. Subsequently, 2 ml of buffer of pH 2.71 was
added to each flask followed by 1 ml each of 0.2% metol and 0.1% sulphanilic acid solutions. The volume
was made up to the mark with distilled water and the absorbance of the resulting purple colour was measured
at 520 nm against the reagent blank prepared under identical conditions but without the drug. Calibration
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graphs were constructed by plotting absorbance versus concentration of the drug in µgml−1. Concentration
of the drug in test solutions was calculated from the calibration graph or the regression equation computed
from the Beer’s law data.

Procedure for Pharmaceutical Preparations
Twenty to 80 tablets containing the phenothiazine drugs studied were ground into a fine powder. An amount
of the powder equivalent to 100 mg of pure drug was weighed into a 100 ml standard flask, and about 60
ml of distilled water was added and shaken thoroughly for about 20 min. The volume was made up to the
mark with distilled water, mixed well and filtered using quantitative filter paper. A 5 or 10 ml aliquot of this
filtrate was then used for analysis by titrimetry. For the spectrophotometric method, the filtrate was diluted
appropriately before taking a suitable aliquot for assay. In the case of injections, the contents of 20 ampoules
were mixed and an accurately measured volume equivalent to 100 mg of the drug was transferred into a 100
ml calibrated flask and diluted to the mark with distilled water. The steps described under the tablets were
then followed. The samples were also analysed by the official methods of the British Pharmacopoeia6 and
the results are given in Table 3.

Results and Discussion
Titrimetry: The procedure is based on the fact that chloramine-T in acidic solution oxidises phenothiazines
first to red, reddish-violet or orange coloured radical cations and finally to colourless sulphoxide42. The effect
of variables such as oxidant concentration, strength of sulphuric acid and the reaction time were studied. It
was found that 10 ml of 0.015 M chloramine-T in 1 M sulphuric acid was suitable for quantitative oxidation.
The reaction was not stoichiometric in hydrochloric or phosphoric acid medium. The oxidation of drugs as
indicated by the disappearance of the colour was found to be completed at room temperature in 20-30 min
depending on the individual phenothiazine derivative.
Two moles of chloramine-T per mole of each drug were required for complete reaction. Prolongation
of the reaction time up to 60 min, had no effect on the stoichiometry and the results in respect of pure
drugs, but the formulations, tablets in particular, were found to consume more oxidant if the back titration
of the unreacted chloramine-T was delayed beyond 15 min. producing erroneous results, due to interference
from sugars. Other additives and excipients like starch, talc, gelatin, alginate and stearate in levels found in
formulations did not interfere under the experimental conditions described. This is due to the preferential
reaction of phenothiazines with chloramine-T and the self-indicating system provided by the phenothiazinium
free radicals.
Spectrophotometry: In mildly acidic conditions, when primary aromatic amines were made to
react with 4-N-methylaminophenol (metol) and chloramine-T, a purple-red colour43 is produced. In the
present investigation, the above observation was utilised for estimating microgram quantities of chloramineT, which formed the basis for the indirect spectrophotometric method for phenothiazines. In the proposed
method, phenothiazines were oxidised to colourless sulphoxides by means of a known and excessive amount of
chloramine-T and the unreacted chloramine-T was determined by metol-sulphanilic acid (primary aromatic
amine) as a chromogenic agent.
Phenothiazines, when added in increasing amounts to a fixed amount of chloramine-T, consume the
oxidant proportionately and, consequently, there is a concomitant fall in the chloramine-T concentration
and this is indicated by the proportional decrease in the absorbance of the chromogen when fixed amounts
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of metol and sulphanilic acid are was used. This decrease in absorbance is proportional to phenothiazine
concentration.
The reaction between phenothiazines and chloramine-T was fast as indicated by the disappearance
of red, reddish-purple or orange colour, which took barely 2-3 min. The various parameters involved in
the formation of the chromogen were optimised. In order to determine Beer’s law limits for chloramine-T,
the absorbance at 520 nm of a series of solutions (10 ml) containing varying amounts of chloramine-T, 2
ml of Walpole buffer of pH 2.71 and specified concentrations of metol and sulphanilic acid (as given in the
procedure) were used. The system was found to obey Beer’s law in the concentration range 5-90 µgml−1 .
In the determination of drugs, varying amounts of drugs were reacted with fixed amounts of chloramineT (750 µg), metol (1 ml of 0.2%) and sulphanilic acid (1 ml of 0.1%) throughout at pH 2.71 in a total volume
of 10 ml.
After the oxidation of phenothiazines, the first step in colour development is the oxidation of metol to
1, 4-benzoquinone-methylimine, which has a short life in aqueous solution, being prone to hydrolysis to 1,
4-benzoquinone and methylamine44, and then its coupling with sulphanilic acid. Neither 1, 4-benzoquinone
nor the mixture of 1,4-benzoquinone and the oxidant will couple with sulphanilic acid to give the colour.
Since chloramine-T is found to react with primary aromatic amines43 , metol should be added first and
sulphanilic acid later, otherwise lower absorbance values will be obtained. Thus, metol should be added
first and then sulphanilic acid. Because of the appreciable loss of 1,4-benzoquinone methylimine by its rapid
hydrolysis, any delay in the addition of the amine also results in low (and variable) absorbance values43,45.
Two blanks were prepared for this system. The reagent blank, which contained optimum concentrations of all the reactants except phenothiazines, gave maximum absorbance. The other blank was prepared
in the absence of chloramine-T to determine the contribution of other reagents to the absorbance of the
system. As the absorbance of the second blank was comparable to that of water, the absorbance of the
developed colour was measured against distilled water. Full colour development took 30 min and was stable
for 30 min. The decreasing absorbance values at 520 nm were plotted against the increasing concentrations
of phenothiazines to obtain the calibration graphs. Beer’s law was obeyed over the concentration ranges
given in Table 2. Correlation coefficients, intercepts and slopes for the calibration data are also presented
in Table 2. The apparent molar absorptivities are around 2x103 1 mol−1 cm−1 .
Table 2. Optical characteristics, precision and accuracy data of spectrophotometric method

Drug

CPH
PH
TPH
TFPH
TPPM
PCPMS

Beer’s
law limit
(µgml−1 )
5-90
5-80
5-90
5-120
10-150
5-100

Molar
absorptivity
(103 × 1
mol−1cm−1 )
1.992
2.018
2.035
1.900
1.808
2.033

Correlation
coefficient (r)
-0.9900
-0.9999
-0.9999
-0.9920
-0.9999
-0.9920

Slope
(b)

Intercept
(a)

Recovery*
(%)

RSD
(%)
(n=7)

-0.0056
-0.0063
-0.0052
-0.0039
-0.0029
-0.0036

0.5190
0.5280
0.5270
0.5196
0.5085
0.5220

98.85
99.05
100.65
98.81
100.01
100.21

0.93
1.04
0.63
0.44
1.07
1.53

* Average of seven determinations each containing 60 µgml−1 of CPH, PH or TPH, 70 µgml−1 of PCPM, 80 µgml−1
of TFPH or 100 µgml−1 of TPPM
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To examine the precision of the procedure, seven replicate determinations were performed on the same
solution containing 60 µgml−1 of CPH, PH or TPH, 70 µgml−1 of PCPMS, 80 µgml−1 of TFPH or 100
µgml−1 of TPPM and % RSD of 0.93, 1.04, 0.63, 0.44, 1.07 and 1.53 respectively, were obtained.
The concomitant substances usually associated with the drugs in the pharmaceutical preparations did
not interfere in the determination.

Application of the methods
The proposed methods were applied to the determination of the studied drugs in pharmaceutical preparations. The results in Table 3 indicate that the methods give good accuracy and precision with satisfactory
agreement with the results obtained by the official method.
Table 3. Assay of phenothiazines in pharmaceutical preparations by the proposed and official methods

Drug and formulation
analysed$
CPH
Megatil tabletsa
Megatil injectionsa
PH
Phena tabletsb
Phenergan injectionsc
TPH
Siquil tabletsd
Siquil injectionsd
TFPH
Trazine tabletse
Neocalm tabletsa
TPPM
Majeptil tabletsc
PCPMS
Stemetil injectionsf

Content per
tablet or per
ml (mg)

Found, % Recovery∗±SD
Proposed methods
Titrimetry
Spectrophotometry
BP method

Student’s
t-value#
T
S

F-value@
T
S

25
50
25

97.46±1.26
100.42±1.02
98.76±1.02

98.58±0.88
99.98±0.64
99.04±0.96

98.85±1.06
100.04±0.85
98.94±0.84

1.89
0.64
0.30

0.44
0.12
0.17

1.41
1.44
1.47

1.45
1.76
1.30

10
25
25

101.16±1.28
98.52±1.64
100.14±1.34

100.98±0.95
99.03±1.26
99.85±0.63

99.85±1.12
98.74±0.76
99.26±0.85

1.72
0.28
1.27

1.72
0.45
1.26

1.30
4.65
2.48

1.38
2.74
1.82

10
10

97.96±1.48
99.26±1.02

98.24±0.96
99.68±0.76

10
10

98.58±1.36
98.27±1.02

99.04±0.66
98.73±0.84

100.06±0.72
99.17±0.53

2.25
1.83

2.33
1.01

3.56
3.70

1.19
2.51

5

99.28±1.54

101.42±1.16

12.5

100.42±0.94

101.03±1.26

100.86±0.84

0.78

0.25

1.25

2.25

* Average of five determinations
# Tabulated t-value at 95% confidence level is 2.75
@ Tabulated F-value at 95% confidence level is 6.39
$ Marketed by: a=Intas, b=Ind-Swift, c=Rhone-Poulenc, d=Sarabhai Chemicals, e=Sun Pharma, f=SmithKline
Beecham
‘T’ stands for titrimetry ‘S’ stands for spectrophotometry

Statistical analysis of the results by Student’s t-test and F-test showed no significant difference in
accuracy and precision between the proposed and official methods.

Conclusion
The salient features of the proposed methods are simplicity, sensitivity (spectrophotometry) and long
dynamic range of determination. The methods do not require special working conditions unlike many other
procedures and thus are suitable for routine analysis of phenothiazines in bulk drugs as well as formulations.
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